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ABSTRACT
Background: Population-based data on the prevalence of cobal-
amin and folate deficiency in India are lacking.
Objective: The objective was to measure the prevalence of cobal-
amin and folate deficiency among children aged 6–30 mo residing in
a low-to-middle income community in North India.
Design: Children aged 6–30 mo (n 2482) were identified through
a community survey in a low-to-middle socioeconomic area in New
Delhi, India. Non-fasting venous blood samples were collected be-
fore enrollment in another trial.
Results: The median (interquartile range; IQR) cobalamin concen-
tration in 6–11-mo-old children was substantially lower in breastfed
(183; 120–263 pmol/L) than in nonbreastfed (334; 235–463
pmol/L) children. Cobalamin concentrations decreased progres-
sively with increasing age in the nonbreastfed children. Median
(IQR) plasma folate concentrations in the 6–11-mo-old group were
higher in breastfed (20.3; 11.7–34.4 nmol/L) than in nonbreastfed
(5.3; 3.4–7.7 nmol/L) children (P  0.001). Folate concentrations
decreased with increasing age in the breastfed children. In the non-
breastfed children, folate concentrations increased with increasing
age. Low concentrations of plasma cobalamin (150 pmol/L) were
detected in 36% of breastfed and 9% of nonbreastfed children (P
0.001). The proportions of children with plasma folate concentra-
tions 5 nmol/L in these 2 subgroups were 6% and 33%, respec-
tively (P 0.001).
Conclusions: In north Indian preschool children, cobalamin and
folate concentrations were commonly low and were associated with
elevated total homocysteine and methylmalonic acid concentrations.
Because low cobalamin and folate concentrations have functional
consequences, population-based measures for improving cobalamin
and folate concentrations need to be seriously considered. Am J
Clin Nutr 2007;86:1302–9.
KEY WORDS Cobalamin, folate, homocysteine, methylma-
lonic acid, children, India
INTRODUCTION
Deficiency and inadequate dietary intake of several micro-
nutrients, including iron, zinc, vitamin A, folate, and cobal-
amin, have been reported in India (1, 2). There is, however, a
paucity of population-based data on the prevalence of cobal-
amin deficiency in children. This is surprising given the high
likelihood of cobalamin deficiency occurring because of pre-
dominantly vegetarian diets and, hence, a low intake of dietary
cobalamin throughout life (3). Most studies from India used
serum or plasma measurements of the vitamins to assess co-
balamin and folate status. These assays have limited sensitiv-
ity (4). Markers of cobalamin function, such as serum or
plasma concentrations of total homocysteine (tHcy) or meth-
ylmalonic acid (MMA) may contribute to identifying mild-
to-moderate cobalamin deficiency (5). Homocysteine remeth-
ylation to methionine requires 5-methyltetrahydrofolate as
cosubstrate and cobalamin as a cofactor. Thus, deficiencies of
folate or cobalamin will lead to elevated plasma tHcy con-
centrations. Cobalamin also functions as a cofactor in a sec-
ond enzyme, methylmalonyl CoA mutase, which explains
elevated concentrations of MMA in cobalamin deficiency. In
subjects with normal renal function, elevation of both MMA
and tHcy concentrations usually indicates a cobalamin defi-
ciency, whereas normal concentrations of MMA and elevated
tHcy concentrations in most cases indicate folate deficiency
(5). Measurement of these indicators, therefore, provides a
more comprehensive assessment of the folate and cobalamin
status in a population. In the present study, we report bio-
chemical evidence of cobalamin and folate deficiencies in
6 –30-mo-old children residing in a low to midlevel socioeco-
nomic urban community in Delhi.
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SUBJECTS AND METHODS
Study population
Children were identified through a survey for a double-blind,
randomized, placebo-controlled trial aimed to assess the effect of
daily zinc supplementation for 4 mo on diarrhea and pneumonia
(6, 7). Children included in the trial were aged 6–30 mo and were
residents of the urban community Dakshinpuri, which comprised
a population of 75 000 individuals residing in 15 000 house-
holds. More details of the study setting, design, and recruitment
procedures were described previously (6, 7).
Briefly, a total of 3802 children aged 6–30 mo were identified
through a door-to-door survey. Exclusion criteria followed the
protocol of the trial, and the reasons for exclusion are shown in
Figure 1. Of the 2482 children randomly assigned into the main
trial, 96 (3.8%) of the parents refused sampling, and blood was
insufficient for analysis in another 90 (3.6%) children. The cur-
rent analysis is accordingly based on 2296 children (Figure 1)
whose blood specimens were collected before initiation of zinc
supplementation or any other intervention. The procedures were
in accordance with the ethical standards of the All India Institute
of Medical Sciences.
Blood sampling procedures
Between 0900 and 1200, nonfasting venous blood specimens
were collected by physicians into heparinized polypropylene
tubes (Sarstedt, Numbrecht, Germany). The heparinized blood
was centrifuged at 447g for 10 min at room temperature within
10 min of collection with portable centrifuges placed at the site
of collection, and plasma was transferred into polypropylene
vials (Eppendorf, Hinz, Germany) and stored at 20 °C until
analyzed.
Plasma concentrations of cobalamin (n 2261) and folate (n
 2296) were determined by microbiological assays using a
chloramphenicol-resistant strain of Lactobacillus casei and
colistin sulfate–resistant strain of Lactobacillus leichmannii, re-
spectively (8, 9). Both assays were adapted to a microtiter plate
format and carried out by a robotic workstation (10). Plasma
concentrations of MMA (n  2271) and tHcy (n  2270) were
analyzed by a modified gas chromatography–mass spectrometry
(GC-MS) method based on ethylchloroformate derivatization
(11).
Data entry and statistical analysis
Data were double entered independently by 2 data clerks into
databases (FoxPro; Microsoft Corporation, Redmond, WA) with
range, consistency, and logic checks. The 2 data sets were
merged after validation, and a backup was kept offsite.
StatisticalanalysiswasperformedwithSTATA(version8;Stata-
corp, College Station, TX). All observations were displayed in scat-
ter plots to identify any outliers. Means, medians, SDs, and inter-
quartile ranges (IQRs) were estimated. For comparison of vitamin
concentrations in breastfed and nonbreastfed children, nonparamet-
ric tests were used. Median concentrations of vitamins and metab-
olites across age categories in breastfed and nonbreastfed children
were compared by using a Kruskal-Wallis test. The interactions
between various categories of cobalamin and folate as dependent
variables and other subgroups as explanatory variables were exam-
ined by multivariate logistic regression. In addition to all the explan-
atory variables as the main effects, all interaction terms up to the
second order were included in the multivariate logistic regression
model. The effect of interaction term was assessed by the level of
significance of each interaction term.
Exclude d 
Nonconsent:  6  78  (1 7 .8% ) 
Li ke ly to move in next 4 mo:  5  67  
(15% ) 
Received vitamin A in the pr ev ious  
2 mo:   5  6  (1 .5% ) 
Illness re qu iring hospitalization: 1 9 (0 .5% ) 
Children aged 6-30 mo   
identified by door-to-door survey  
(n=3802)
Randomly assigned (n=2482) 
pl ac ebo  in the main tr ia l 
Reasons Venous Blood Specimens  
Not Ob tained or  An al yz ed 
Refused sampling: 96 (3.8%) 
Insuffic ie nt quantity fo r  anal ysis : 90  
(3.6%) 
Ba se line venous blood specimens  
anal yz ed  
for one or more parameters  (n=2296)
Plas ma  
cobalami n
(n=2261)
Plas ma  
folate 
(n=2296)
Plas ma  
MMA 
(n=2271)
Plas ma  
tHcy 
(n=2270)
 to zinc or 
FIGURE 1. Trial profile.
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We used generalized additive model (GAM) plots in the pack-
age “mgcr” in the statistical software R (12, 13) to depict the
dose-response relation between age, breastfeeding status, and
vitamin or metabolite concentrations. The significance level was
set at 0.05.
RESULTS
The demographic characteristics of the included children are
shown in Table 1. The mean age at enrollment was 15.3 mo;
50% of the children were boys and 69% were breastfed. There
was a significant interaction of age and breastfeeding with co-
balamin, folate, tHcy, and MMA (P  0.001 in each instance).
The median and interquartile ranges of cobalamin, folate, tHcy,
and MMA values are given in Table 2 by breastfeeding status
and age.
Overall in the breastfed children, median cobalamin concen-
trations were lower (178.3 compared with 277), whereas folate
(14.3 compared with 6.3), tHcy (12 compared with 9.2), and
MMA (0.9 compared with 0.4) concentrations were higher than
in nonbreastfed children (P 0.001 for all comparisons).
Across the age categories 6–11, 12–23, and 24–30 mo, me-
dian plasma folate, tHcy, and MMA were significantly different
(P  0.001 for each) in breastfed children. In the nonbreastfed
children, all of these variables and cobalamin concentrations
were different across the same age subgroups (P  0.001 for
each).
In simple correlation analysis, the cobalamin concentration
was inversely associated with tHcy in breastfed (r0.53, P
0.001) and nonbreastfed (r  0.24, P  0.001) children. The
cobalamin concentration was also inversely associated with
MMA concentrations in breastfed (r  0.44, P  0.001) and
nonbreastfed (r  0.39, P  0.001) children. Folate concen-
trations showed an inverse correlation with tHcy (r0.35, P
 0.001) and MMA (r0.07, P 0.061) in the nonbreastfed
children. However, in breastfed children there was a significant
positive association of folate with tHcy (r0.28, P0.001) and
MMA (r 0.34, P 0.001). The correlation between folate and
MMA and between folate and tHcy in nonbreastfed children was
significantly different (P  0.001) from the respective correla-
tion in breastfed children (14).
Plasma cobalamin and folate
Various reference limits for cobalamin and folate were used
previously, but none are available for tHcy and MMA in children.
Many studies have used either 150 or 200 pmol/L as cutoffs for
defining cobalamin deficiency and 5 or 7.5 nmol/L for defining
folate deficiency (15–17). Twenty-eight percent (breastfed:
36%; nonbreastfed: 9%) of the children had plasma cobalamin
concentrations150 pmol/L, 48% (breastfed: 58%; nonbreast-
fed: 24%) had concentrations200 pmol/L, and 64% (breastfed:
73%; nonbreastfed: 43%) had concentrations 250 pmol/L.
TABLE 1
Baseline characteristics of the study children aged 6–30 mo, who resided
in a low-to-middle income community of Delhi, India
Characteristics Total group (n 2296)
Age (mo) 15.3 7.51
Male [n (%)] 1205 (52.5)
Breastfed [n (%)] 1585 (69.0)
Weight (kg) 8.1 1.6
Length (cm) 72.7 7.2
Mother literate [n (%)] 1473 (64.4)
Annual family income (rupees)2 36 000 (24 000, 54 000)3
1 x  SD (all such values).
2 One US dollar 44 rupees.
3 Median; interquartile range in parenthesis.
TABLE 2
Plasma cobalamin, folate, methylmalonic acid (MMA), and total homocysteine (tHcy) concentrations in the study children at different ages according to
breastfeeding status1
Breastfed children Nonbreastfed children
6–11 mo 12–23 mo 24–30 mo 6–11 mo 12–23 mo 24–30 mo
Cobalamin (pmol/L)
n 776 609 178 144 310 244
Median 183.8 171.6 180.5 334.0 284.5 230.9
IQR 120–263 120–250 132–264 234–463 212–381 178–321
Folate (nmol/L)
n 791 614 180 143 316 252
Median 20.2 11.9 9.3 5.3 5.8 7.4
IQR 11.7–34.4 7.9–18.9 6.6–13.6 3.4–7.7 4.3–8.2 5.3–10.1
tHcy (mol/L)
n 780 609 179 142 313 247
Median 12.6 11.5 10.3 10.7 9.1 9.1
IQR 9.2–18.1 8.9–16.1 8.5–13.5 8.2–13.9 7.5–11.2 7.2–11.1
MMA (mol/L)
n 770 609 178 142 314 247
Median 1.03 0.79 0.60 0.44 0.37 0.41
IQR 0.53–2.08 0.45–1.48 0.36–1.02 0.31–0.71 0.25–0.53 0.26–0.64
1 IQR, interquartile range. For cobalamin, folate, tHcy, and MMA, the interaction between breastfeeding and age was significant (P 0.001 for each);
test of interaction. Median values across age categories are significantly different for folate, tHcy, and MMA in the breastfed children (P 0.001 for each) and
for all 4 metabolites in the nonbreastfed children (P  0.001 for each); Kruskal-Wallis test. Values were significantly different between breastfed and
nonbreastfed children, P 0.001 (k sample equality median test).
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With regard to folate, 15% (breastfed: 6%; nonbreastfed: 33%)
had concentrations5 nmol/L, 32% (breastfed: 18%; nonbreast-
fed: 63%) had concentrations7.5 nmol/L, and 46% (breastfed:
30%; nonbreastfed: 82%) had concentrations10 nmol/L.
The distribution of plasma cobalamin concentrations in rela-
tion to several baseline characteristics of the children is shown in
Table 3. Of the subgroup with plasma cobalamin concentrations
150 pmol/L, only 31 (4.9%) had folate concentrations 5
nmol/L, and 83 (13.1%) had concentrations 7.5 nmol/L (data
not shown).
The distribution of plasma folate concentrations by age,
breastfeeding status, and metabolite concentrations is shown in
Table 4. Overall, 31 of the 2296 study children had both plasma
cobalamin concentrations 150 pmol/L and folate concentra-
tions5 nmol/L. In a multivariate logistic model, the interaction
among all explanatory variables shown in Table 4 was deter-
mined, and there was a significant interaction only of breastfeed-
ing with age and with tHcy across various categories of plasma
folate (P 0.001; data not shown).
We used GAM to describe the associations between vitamin
concentrations and the metabolites adjusted for age in the
breastfed and nonbreastfed children (Figure 2). In relation to
folate, the GAM curves showed a marked difference between
breastfed and nonbreastfed children. In breastfed children,
folate was positively associated with tHcy, with no apparent
threshold effects. In nonbreastfed children, the expected in-
verse association between folate and tHcy was apparent (Fig-
ure 2). For cobalamin, the GAM curves showed that in breast-
fed children the metabolite concentrations start to decline at
lower cobalamin concentrations and more sharply than in
nonbreastfed children. The thresholds were less distinct for
the nonbreastfed children.
DISCUSSION
Assuming that our cutoff values for defining deficiency are
appropriate, the current study highlights the very common oc-
currence of cobalamin and folate deficiency in young Indian
children. Cobalamin deficiency affected nearly 1 of every 3 chil-
dren, and some of the others might well have milder degrees of
deficiency. Several studies in India have reported cobalamin and
folate deficiency, hyperhomocysteinemia, and elevated plasma
MMA concentrations in 50% to 66% of adults in different parts
of India (16, 18, 19). However, few population-based estimates
of cobalamin and folate deficiency among preschool children are
available. The available studies in children who were either at-
tending school or visiting hospitals (20–24) have shown that
33% have low plasma cobalamin and 5–20% have low plasma
folate (23, 24) concentrations. A poor cobalamin status of moth-
ers may be an important factor in the high prevalence of cobal-
amin deficiency observed in the present study. This may be
caused by limited cobalamin transfer across the placenta leading
to low cobalamin stores in newborns and by a low content in
breast milk (25, 26).
Dietary habits were not documented in the current study.
According to previous studies conducted in this population,
most families are vegetarian (27). Milk cobalamin concentra-
tions are lower in women consuming a strict vegetarian diet
than in those consuming an omnivorous diet (28). In this
setting, breastfeeding during the first year is generally the
rule, the introduction of complementary foods is delayed, and
the intake of such foods is low (29, 30). Foods of animal origin
are very uncommonly offered to young children. The con-
sumption of fortified cereals and dairy products is low in both
mothers and children (2). Gastrointestinal infections, intesti-
nal bacterial overgrowth, and giardiasis are common (31–33).
TABLE 3
Differences in baseline variables by plasma cobalamin concentration in the study children1
Characteristics
Categories of plasma cobalamin (pmol/L)
P2
150
(n 639)
150 to 200
(n 445)
200
(n 1177)
Age (mo) 14.6 7.23 15.4 7.6 15.6 7.64 0.018
Age 6–11 mo [n (%)] 284 (44.4) 181 (40.7) 455 (38.7) 0.057
Age 12–30 mo [n (%)] 355 (55.5) 264 (59.3) 722 (61.3)
Sex [n (%)]
Male 308 (48.2) 223 (50.1) 651 (55.3)4 0.009
Female 331 (51.8) 222 (49.9) 526 (44.7)
Breastfeeding status [n (%)]
Breastfed 572 (89.5) 341 (76.6)4 650 (55.2)4,5 0.001
Nonbreastfed 67 (10.5) 104 (23.3) 527 (44.8)
Plasma folate (nmol/L) 23.0 16.9 [635] 16.7 14.34 [44] 11.5 10.14,5 [1172] 0.001
5 nmol/L [n (%)] 31 (4.9) 52 (11.8) 250 (21.3)4,5 0.001
5 nmol/L [n (%)] 604 (95.1) 390 (88.2) 922 (78.7)
Plasma tHcy (mol/L) 18.0 9.1 [632] 12.0 4.84 [442] 10.1 3.94,5 [1165] 0.001
Plasma MMA (mol/L) 2.33 3.35 1.02 1.214 0.77 1.994 0.001
1 n values in brackets. tHcy, total homocysteine; MMA, methylmalonic acid.
2 Chi-square test used for proportions and ANOVA used for means.
3 x  SD (all such values).
4 Significantly different from subjects with a cobalamin concentration of150 pmol/L, P 0.015 (Bonferroni correction).
5 Significantly different from subjects with a cobalamin concentration of 150–200 pmol/L, P 0.015 (Bonferroni correction).
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These factors have been reported to be contributory factors to
cobalamin deficiency.
The present study showed the importance of breastfeeding in
protecting against folate deficiency. Folate concentrations in
breast milk are usually quite high (34), and folate is the only
vitamin of the B group whose concentration in breast milk is
independent of maternal intake and status (35). Note, however,
that this is generally true in folate-replete populations, and it is
not clear whether it would hold true for a folate-deplete popula-
tion.
The public health significance of cobalamin deficiency is not
well recognized despite its high prevalence. Studies in India and
Nepal show that this may be because severe cobalamin defi-
ciency can occur without the classic signs of anemia or macro-
cytosis (16, 36–39). The possibility that adequate folate intake
protects against anemia in some subjects with cobalamin defi-
ciency and, therefore, masks its other biological effects has been
proposed (40). Leukocytosis and thrombocytopenia have been
frequently reported in children and in adults with low cobalamin
concentrations (24, 36). Interestingly, in a rotavirus vaccine trial
at the same site where we undertook the current study, leukopenia
was reported to be unexpectedly common among otherwise
healthy infants aged 6–8 wk (41). Symptoms attributed to co-
balamin deficiency include failure to thrive, movement disor-
ders, psychomotor developmental delay and regression, and
megaloblastosis, but neurologic symptoms can develop even
without hematologic abnormalities (26). In apparently healthy
children from macrobiotic families, who adhere to a strict veg-
etarian diet, metabolic signs of persistent cobalamin deficiency
and impaired cognitive performance may prevail during adoles-
cence and even after initiating consumption of animal products
(42, 43).
A recent report on the incidence of neural tube defects in
village clusters in one of the most underdeveloped areas of India
showed an incidence of 6.7 to 8.2 per thousand live births (44).
This risk is one of the highest in the world. Potential etiologic
factors are deficiency of folate and possibly of cobalamin or
vitamin B-6 (45). Furthermore, hyperhomocysteinemia has been
reported in nearly 75% of Indian adults, and vegetarianism and
several poverty-related factors may be important in its etiology
(16, 46).
Several potential limitations of this study are noteworthy. The
estimate of deficiency across studies may vary because of factors
other than actual differences. These factors include the nature of
the assays used, the fasting or nonfasting status at the time of
specimen collection, and incipient dehydration as a result of mild
diarrheal illnesses that are common in developing countries.
Considerable variation is reported for folate estimates by various
assays and across laboratories.
In general, microbiological assays have tended to have larger
CVs than radioimmunoassays. This variability must invariably
influence the comparison of folate deficiency estimates across
studies (47). In the current study, blood was obtained in a non-
fasting state because of the young age of the children, which
TABLE 4
Differences in baseline variables by plasma folate concentration in the study population1
Characteristics
Categories of plasma folate (nmol/L)
P2
5
(n 335)
5 to	7.5
(n 409)
7.5
(n 1552)
Age (mo) 16.5 6.93 18.9 7.34 14.1 7.44,5 0.001
Age 6–11 mo [n (%)] 100 (29.9) 92 (22.5) 742 (47.8) 0.001
Breastfed 7.9 1.8 [32] 8.1 1.7 [54] 7.5 1.7 [705] 0.595
Nonbreastfed 8.1 1.8 [68] 8.1 1.7 [38] 8.2 1.9 [37] 0.908
Age 12–30 mo [n (%)] 235 (70.2) 317 (77.5) 810 (52.5) 0.001
Breastfed 19.5 4.8 [69] 21.1 4.6 [136] 18.8 4.95 [589] 0.671
Nonbreastfed 20.3 4.8 [166] 22.7 5.04 [181] 23.4 4.64 [221] 0.449
Sex [n (%)]
Male 183 (54.6) 217 (53.1) 805 (51.9) 0.636
Female 152 (45.4) 192 (46.9) 747 (48.1)
Breastfeeding status [n (%)]
Breastfed 101 (30.1) 190 (46.4) 1294 (83.4) 0.001
Nonbreastfed 234 (69.8) 219 (53.5) 258 (16.6)
Plasma cobalamin (pmol/L) 307.7 149.9 [333] 281.3 132.7 [400] 209.7 128.94,5 [1016] 0.001
150 pmol/L [n (%)] 31 (9.3) 52 (13.0) 552 (36.4)
150 to	200 pmol/L [n (%)] 52 (15.6) 71 (17.8) 319 (21.0)
200 pmol/L [n (%)] 250 (75.1) 277 (69.3) 646 (42.6)
Plasma tHcy (mol/L) 11.7 4.7 [332] 10.6 4.0 [404] 13.5 7.74,5 [1524] 0.001
Breastfed 11.7 3.8 [100] 11.4 4.6 [189] 14.5 8.04,5 [1270] 0.001
Nonbreastfed 11.8 5.1 [232] 9.9 3.34 [215] 8.8 3.14 [254]
Plasma MMA (mol/L) 0.65 0.96 0.68 0.78 1.58 2.914,5 0.001
1 n values in brackets. tHcy, total homocysteine; MMA, methylmalonic acid. Comparison of all 3 folate and cobalamin categories: P  0.001 (overall
chi-square test for proportions). Interaction of breastfeeding with age and tHcy across plasma folate categories: P 0.001 (multivariate logistic model).
2 Chi-square test used for proportions and ANOVA used for means.
3 x  SD (all such values).
4 Significantly different from subjects with a folate concentration of5 nmol/L, P 0.015 (Bonferroni correction).
5 Significantly different from subjects with a folate concentration of 5–7.5 nmol/L, P 0.015 (Bonferroni correction).
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FIGURE 2. Relation between total homocysteine (tHcy) and methylmalonic acid (MMA) concentrations with cobalamin and folate concentrations in
breastfed and nonbreastfed children. The graphs were made by using generalized additive models in R (13). The results are adjusted for age. The solid lines
represent the estimated dose-response curves; the dashed lines represent the 95% CIs. The horizontal lines depict suggested thresholds. For the relations between
cobalamin and MMA and tHcy, the thresholds are not clearly distinct; therefore, the estimates of proportion with low cobalamin concentrations are more
uncertain. In the regression models that were the basis for these dose-response graphs, the P value for the interaction of breastfeeding and cobalamin with MMA
and tHcy and the P value for the interaction of breastfeeding and folate with tHcy were both0.001.
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could have falsely elevated plasma folate concentrations and led
to an underestimation of the prevalence of folate deficiency.
Although mild diarrheal illness in a proportion of children at the
time of blood collection cannot be totally ruled out, it is unlikely
to be a major factor because children were considered for enroll-
ment only after recovery from any significant illness. We did not
specifically monitor the use of iron or folic acid supplements by
children. However, previous program assessments have shown
that compliance with iron–folic acid programs is very low for
young children. Nevertheless, these factors could potentially
lead to an underestimate of folate deficiency. The availability of
detailed dietary intakes could have facilitated better interpreta-
tion of the study findings, but such data are regrettably not avail-
able. The availability of blood counts would have helped to
provide clinical validity to the vitamin-deficiency data. Finally,
we did not obtain vitamin B-6 data and, therefore, cannot com-
ment on any possible effect of its deficiency on the observed
homocysteine values.
On the other hand, despite these potential limitations, this
study has yielded one of the very few population-based estimates
of cobalamin and folate deficiency levels in Indian children.
Plasma concentrations of folate and tHcy are usually inversely
correlated (48). Thus, a surprising finding in our population was
the positive association between folate and tHcy in the breastfed
children. One possible explanation could be that the breastfed
children had a cobalamin deficiency. Elevated folate concentra-
tions in cobalamin-deficient subjects has been reported earlier
(49) and has been explained by the so called “folate trap” mech-
anism (50). Furthermore, this phenomenon may obscure the as-
sessment of folate status in cobalamin-deficient subjects (51).
The findings of this study, when viewed together with those of
other studies in Indian adults and children, suggest that cobal-
amin and folate deficiencies are important public health prob-
lems that merit priority attention and effective control. Possible
remedial measures include dietary modification, supplementa-
tion, and fortification of specific foods, mainly those that are
commercially processed.
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